Would you get a one-time genetic modification such that you'd never have to take a GLP-1 drug for weight loss ever again?

The FDA has issued a warning about counterfeit Ozempic medications, sharing the lot numbers and serial numbers of products that should not be used, sold or distributed.

Semaglutide is a drug that can be used for weight loss. Oral tablets and injections are both effective ways to take semaglutide.

A slow-release form of semaglutide could allow people who use Wegovy or Ozempic to get shots once a month, instead of the weekly injections they now take, a new study demonstrates.

Compounded semaglutide is a non-FDA-approved alternative to products that contain semaglutide, such as Ozempic. Learn how the safety and efficacy of compounded semaglutide compares with Ozempic.

Semaglutide injections reversed some cases of MASH liver disease in clinical trials, reducing inflammation in 62.9% of patients and offering new hope for those with the life-threatening condition.

WEDNESDAY, Sept. 11, 2024 (HealthDay News) -- A new study shows that a slow-release form of semaglutide could enable people using Wegovy or Ozempic to switch from weekly to once-a-month injections.

Ozempic (semaglutide) may cause side effects like abdominal pain, diarrhea, nausea, and vomiting. Less common ones are dry mouth and low blood sugar.

FDA warns of fake Ozempic The FDA and drugmaker Novo Nordisk on Monday warned that counterfeit vials of Ozempic® (semaglutide) are being sold to consumers and may cause a safety risk.

Semaglutide — the active ingredient in the brand-name meds Ozempic, Wegovy, and Rybelsus — treats type 2 diabetes and obesity or overweight.

The manufacture advices retail pharmacies to purchase authentic Ozempic (semaglutide) injection 1 mg and other semaglutide-containing medicines through authorized distributors of Novo Nordisk.

The FDA and the maker of the popular diabetes and weight loss drug Ozempic are warning people not to use counterfeit semaglutide 1.0 milligrams — the Ozempic injection — found in the U.S. drug ...